The ARC Training Centre for Personalised Therapeutics Technologies aims to create and develop the skills and technology to benefit from the transformative impacts that cell/organ-on-a-chip technology will have on the medtech/pharma industries.

By combining microfluidics-based/real-time technologies with personalised medicine the Training Centre will provide industry growth opportunities through improved screening of potential therapeutics.

The use of an individual patient’s cellular and molecular research findings will ultimately enable personalised diagnostic and therapeutic decisions.

Funding body

Australian Research Council

Scheme name

Industrial Transformation Training Centres

Years funded

2017 – 2021

Lead institution

University of Melbourne

Partner institutions

University of Western Australia; Monash University; Biointelect Pty Ltd; SMR Automotive Australia Pty Ltd; Biosensis Pty Ltd; Commonwealth Scientific and Industrial Research Organisation; Proteomics International Pty Ltd; Orthocell Limited; Epichem Pty Ltd; Wrays Pty Ltd; RSM Australia Pty Ltd; GBS Venture Partners Pty Ltd; Aspect Biosystems Ltd; Clearbridge BioMedics Pte Ltd; National University of Singapore; Trajan Scientific and Medical Pty Ltd; Australian Mathematical Sciences Institute; Biocurate Pty Ltd; Therapeutic Goods Administration; Thomson Reuters